Back to Top Skip to main content

Understanding the potential of COVID-19 convalescent plasma

Researcher scans a unit of plasma in lab. U.S. Army Sgt. Reginald Miles labels donated liquid plasma at the Landstuhl Blood Donor Center. Researchers are studying COVID-19 convalescent plasma to harness the power of neutralizing antibodies to help patients. (Photo by Volker Ramspott)

Recommended Content:

Coronavirus | Convalescent Plasma Collection Program | Armed Services Blood Program

The Department of Defense has set a goal to collect more than 8,000 donated units of plasma from patients who have recovered from COVID-19 by Sept. 30, 2020. This blood will be used to treat critically ill patients and support the development of an effective treatment against the disease.

Like a missile locking on its target, antibodies attack invaders inside the body with a singularity of purpose: search and destroy. Typically, infection-fighting white blood cells produce antibodies as an appropriate response to an invading germ. In some people whose immune systems can’t mount a sufficient attack against a virus, donated antibodies from another person’s plasma may help. Researchers believe the power of antibodies lies in their ability to bind to a virus and neutralize it, or block it from entering cells, said Dr. Kayvon Modjarrad, director of the Emerging Infectious Diseases Branch at the Walter Reed Army Institute of Research in Silver Spring, Maryland. Modjarrad leads the Army’s COVID-19 vaccine development research.

But not all antibodies are created the same. “Antibodies come in different flavors, some of them are neutralizing and some of them are non-neutralizing and we don’t know exactly which individuals are developing what type of antibody,” said Shelly Krebs, chief of B Cell Biology Core at WRAIR Military HIV Research program.

COVID-19 convalescent plasma, or CCP, from a recovered patient could be a mixture of both neutralizing and non-neutralizing antibodies. In fact, people infected with COVID-19 can have varying antibody responses. Some may not have enough antibodies in their plasma to benefit another patient, which is why CCP first needs to be tested for neutralizing antibody levels before transfusing, explained Modjarrad. His lab works to understand the mechanism of COVID-19 antibodies to predict the levels required to offer a person protection from the virus.

Transfusing antibodies provides short-term immunity as the donor antibodies last several weeks to months inside the body, said Navy Capt. (Dr.) Todd Gleeson of the Navy Bloodborne Infection Management Center, located at Naval Support Activity Bethesda, Maryland. “It is likely that a person with COVID-19 who receives CCP will also still develop their own immune cells and produce antibodies to fight the virus if that person is re-exposed in the future,” said Gleeson, who leads a convalescent plasma study of patients at Walter Reed National Military Medical Center also at NSAB in Bethesda. But scientists just can’t confirm that yet. They hope to uncover the answer and many more as they study CCP and COVID-19 antibodies to better treat patients and develop future vaccines.

Military medical treatment facilities will soon take part in an observational study across the Department of Defense to help researchers track trends among patients with COVID-19. The data will help trace recovered patients to ask for CCP donations as the DoD seeks to build a storehouse of CCP for patients admitted to Military Health System facilities and those deployed outside the U.S., explained Army Col. (Dr.) Andrew Cap, director of research at the Army Institute of Surgical Research in San Antonio, Texas. “The goal is to build a convalescent plasma capability within the DoD, both on the collection and on the treatment side,” said Cap, who helped draft a CCP protocol for the DoD.

Future research may lead to the development of highly concentrated neutralizing antibodies extracted from large quantities of convalescent plasma as a potential therapy for prevention and treatment, added Cap.

Scientists believe monoclonal antibodies—derived from a single immune cell—may also hold potential as both a treatment and preventive measure against COVID-19. Krebs and her team have engineered monoclonal antibodies in the lab by isolating the best neutralizing antibodies from CCP samples to create an army of exact replicas that target the COVID-19 virus down to the atomic level, explained Modjarrad. “We know where and how well it’s going to target, and we know the kinetics of how long it will last in the body and how long it will provide protection,” he explained, noting convalescent plasma does not provide that level of effectiveness. “CCP is not generally used for prevention but for treatment.” Monoclonal antibodies could be used for both treatment and prevention of COVID-19 because the transfused neutralizing antibodies would provide immediate immunity, he added.

Monoclonal antibodies have been in use for decades and revolutionized cancer treatment. Krebs’ lab plans to expand the research into monoclonal antibodies against COVID-19 into animal studies this summer. “Our primary goal is to come up with a treatment for people who have COVID-19,” she said.

Anyone able to donate convalescent plasma should contact the Armed Services Blood Program or go online to find a complete list of available collection centers.

You also may be interested in...

DHA-IPM 20-004: Department of Defense (DoD) Coronavirus Disease 2019 (COVID-19) Vaccination Program Implementation

Policy

This Defense Health Agency (DHA) Interim Procedures Memorandum (IPM), based on the authority of References (a) through (d), and in accordance with the guidance cited in References (e) through (aa), establishes the DHA’s procedures to implement instructions, assign responsibilities, and prescribe procedures for the COVID-19 Vaccination Program. This DHA-IPM applies to DHA, DHA Components (activities under the authority direction, and control of the DHA), Military Departments (MILDEP), and the United States Coast Guard (CG). This DHA-IPM cancels and replaces DHA-IPM 20-004, “Department of Defense (DoD) Coronavirus Disease 2019 (COVID-19) Vaccination Program Implementation,” December 13, 2020.

Supplemental Guidance for Providing DoD Coronavirus Disease 2019 Vaccines to DoD Contractor Employees and Select Foreign Nationals

Policy

This memorandum provides supplemental guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines, in accordance with reference (a). The Defense Health Agency (DHA) is the lead coordinating DoD Component for executing this guidance, in coordination with the Military Departments and other DoD Components as appropriate.

MTFs respond to COVID-19 with increased telehealth, drive-thrus

Article
12/29/2020
Military physician sitting at desk, talking to patient on his computer

COVID MTF innovations include more virtual health options and drive thrus.

Recommended Content:

Coronavirus | Technology

MHS Minute: December 2020

Video
12/28/2020
DHA Seal

See how MHS is leading a phased approach to offer 11.1 million Department of Defense personnel the first COVID-19 vaccines. To learn more about the safety and efficacy behind COVID-19 vaccines, go to: https://www.health.mil/Military-Health-Topics/Combat-Support/Public-Health/Coronavirus/COVID-19-Vaccine-Efforts.

Recommended Content:

COVID-19 Vaccine Efforts | Coronavirus | COVID-19 Vaccine Toolkit

HHS and DOD statements on FDA authorization of Moderna vaccine

Article
12/28/2020
Image with documents and vaccine products laying on table

Operation Warp Speed has allocated more than 5.9 million doses of the vaccine for jurisdictions to receive in the coming week.

Recommended Content:

Coronavirus | COVID-19 Vaccine Efforts | Vaccine Trials

Protecting the Force: How the MHS helped sustain readiness in the face of COVID

Article
12/23/2020
Hospital personnel treating a patient on a stretcher

The Military Health System is reviewing how it kept warfighters mission-ready and units online in 2020 during the ongoing pandemic.

Recommended Content:

December Toolkit | Combat Support | Coronavirus

AFHSD’s GEIS collect data worldwide to support force protection

Article
12/22/2020
Medical personnel scanning forehead of soldier with thermometer

AFHSD/GEIS continue work with partners across the globe in their efforts to combat COVID-19 and protect military readiness.

Recommended Content:

Health Readiness | Public Health | Coronavirus | Biological Surveillance Tools | Global Health Engagement | Armed Forces Health Surveillance Branch | COVID-19 Vaccine Efforts

MHS Team Resiliency Awards recognize medical response to COVID-19

Article
12/22/2020
Sailors wearing masks, leaning on a table and writing on sheets of paper

Outstanding efforts recognized during Resiliency Awards

Recommended Content:

Coronavirus | Research and Innovation

Military Health System encourages influenza vaccination for 2020

Article
12/21/2020
Military personnel giving patient a flu vaccine in her left arm

The CDC notes that COVID-19 seems to spread more easily than flu and causes more serious illnesses in some people.

Recommended Content:

Influenza, Northern Hemisphere | Influenza, Southern Hemisphere | Influenza Summary and Reports | Coronavirus | Public Health

MHS COVID Response

Video
12/21/2020
DHA Seal

The men and women of the Military Health System spent 2020 working to protect beneficiaries' health during the coronavirus pandemic. Here are just a few of our accomplishments.

Recommended Content:

Coronavirus

Frontline Indiana Guardsmen receive COVID-19 vaccination

Article
12/18/2020
Soldier getting a vaccine in his left arm

These Guardsmen are trained medics who also took Centers for Disease Control and Prevention courses specific to the coronavirus.

Recommended Content:

Coronavirus | COVID-19 Vaccine Efforts | COVID-19 Vaccine Toolkit

Defense Health Agency Director: Vaccine rollout safe and effective

Article
12/18/2020
Military personnel giving a vaccine to a soldier in her right arm

“In the coming months as the vaccine becomes more widely available, we strongly encourage everyone to get this vaccine,” Place stressed.

Recommended Content:

COVID-19 Vaccine Toolkit | Coronavirus | COVID-19 Vaccine Efforts

COVID-19 surge spurs readiness efforts at Brooke Army Medical Center

Article
12/17/2020
Two hospital personnel, wearing masks, looking at a computer screen

Equipped with lessons learned, BAMC is preparing to shift resources and personnel to ensure hospital readiness in the event of a patient increase.

Recommended Content:

Coronavirus

CDC provides COVID-19 vaccine best practices for healthcare providers

Article
12/17/2020
Medical personnel filling a syringe from a vaccine bottle

[T]he Defense Health Agency’s Immunization Healthcare Division (IHD) is working in collaboration with the CDC to offer the training to the Military Health System’s health care providers.

Recommended Content:

Coronavirus | COVID-19 Vaccine Efforts | COVID-19 Vaccine Toolkit

Top five digital health trends for military medical providers in 2021

Article
12/17/2020
Image of Dr. Pincus with text "Top Five Digital Health Trends for Military Medical Providers in 2021"

One way the MHS will provide...improved care is through DoD’s new electronic health record MHS GENESIS, which will continue its rollout through 2023.

Recommended Content:

Coronavirus | MHS GENESIS
<< < 1 2 3 4 5  ... > >> 
Showing results 61 - 75 Page 5 of 28

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.